This statistic shows the number of inspections the Food and Drug Administration (FDA) made of domestic and foreign medical device establishments in the U.S. from FY 2009 to FY 2024. In FY 2024, the FD
Additional file 1: Clinical studies. Details of clinical studies associated with new drug and biologic license applications in rare diseases that contain real-world data.
Objectives: This study examines the characteristics of studies that Health Canada uses to grant full marketing authorization for products given a conditional approval between January 1, 1998 and June
